Study | Criteria for optimal expanded stent |
Katrisis | Full stent apposition, MSA ≥ 90% mean MLA symmetrical expansion (min SD/max SD > 0.7) (correlation with FFR 0.94) |
Fearon | MSA 7 mm2 (correlation with FFR 0.94) |
Hanekamp | Full stent apposition, MSA ≥ 90% mean MLA or MSA ≥ 100% min MLA symmetrical expansion (min SD/max SD > 0.7) (correlation with FFR 0.94) |
Gorge | symmetrical expansion, MSD ≥ 3 mm, full apposition |
Choi | Complete stent apposition, MSA ≥ 80% distal MLA symmetrical expansion (min SD/max SD > 0.8) |
Colombo | Full stent apposition, MSA ≥ min MLA MLA > 60% MLA in edge regions |
Ahmed | Complete stent apposition, MSA ≥ 80% mean MLA or MSA 7.5 mm2 |
MUSIC | - Complete stent apposition, MSA ≥ 90% mean MLA or ≥ 100 min MLA - In case of >9 mm2: MSA ≥ 80% mean MLA or ≥ min MLA MSA in proximal part of the stent ≥ 90% prox MLA Symmetrical expansion (minSD/maxSD > 0.7) |
Blasini | Full stent apposition, MSA > 8 mm2, or MSA ≥ 90% mean MLA, complete coverage of dissection |
RESIST | MSA ≥ 80% mean MLA |
OPTICUS | MUSIC criteria, residual stenosis < 10% (angiographically) |
CRUISE | Residual stenosis < 10% (angiographically) |
AVID | Full stent apposition, residual stenosis < 10%, no signs of dissection |
TULIP | Complete stent apposition, MSD ≥ 80% mean MLD, MSA ≥ 90% distal MLA |